Document Detail


BDNF and CREB1 genetic variants interact to affect antidepressant treatment outcomes in geriatric depression.
MedLine Citation:
PMID:  23619509     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIM: Brain-derived neurotrophic factor (BDNF) is associated with antidepressant response on the cellular level, in animal models, and in clinical studies. A common variant in the BDNF gene results in a substitution of a methionine (Met) for a valine at the amino acid position 66. Previous studies reported that the Met variant results in enhanced response to antidepressant medications. These findings may be at odds with studies indicating that on a cellular level the Met variant impairs the secretion of BDNF.
MATERIALS AND METHODS: We examined the effects of BDNF single nucleotide polymorphisms (SNPs) in response to the antidepressants paroxetine and mirtazapine in a sample of 246 geriatric patients with major depression, treated in a double-blind, randomized, 8-week clinical trial. We also examined the effects of genetic variation at the BDNF-related loci neurotrophic tyrosine kinase receptor 2, cyclic AMP responsive element binding protein 1 (CREB1), and CREB binding protein. A total of 53 SNPs were genotyped.
RESULTS: BDNF genetic variation had a significant effect on the efficacy of paroxetine, with patients carrying the Met allele showing impaired response. SNPs at the CREB1 locus, which encodes a transcription factor important in BDNF signaling, also predicted response to paroxetine. Furthermore, we found a significant gene-gene interaction between BDNF and CREB1 that affected response to paroxetine. Because BDNF has been associated with cognitive function, we tested the effects of BDNF SNPs on change in a wide variety of cognitive tests over the 8-week trial, but there were no significant effects of genotype on cognition.
CONCLUSION: These results provide new evidence for the importance of the BDNF pathway in antidepressant response in geriatric patients. The negative effect of the Met66 allele on antidepressant outcomes is consistent with basic science findings indicating a negative effect of this variant on BDNF activity in the brain. Further, the effect of BDNF genetic variation on antidepressant treatment is modified by variation in the gene encoding the downstream effector CREB1.
Authors:
Greer M Murphy; Jane E Sarginson; Heather S Ryan; Ruth O'Hara; Alan F Schatzberg; Laura C Lazzeroni
Related Documents :
9435339 - A major histocompatibility complex class i allele shared by two species of chimpanzee.
8105089 - Major histocompatibility complex class ii polymorphisms in humans and chimpanzees.
11884689 - The dominance of alleles controlling self-incompatibility in brassica pollen is regulat...
1350869 - Hla-dp antigen and takayasu arteritis.
10199919 - Characterization of mhc-drb allelic diversity in white-tailed deer (odocoileus virginia...
8515209 - Genetic typing of hla class ii genes in swedish populations: application to forensic an...
22058429 - Linkage and association analyses of glaucoma related traits in a large pedigree from a ...
24428209 - Association analysis of fiber quality traits and exploration of elite alleles in upland...
24276449 - Mosaicism in hif2a-related polycythaemia-paraganglioma syndrome.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pharmacogenetics and genomics     Volume:  23     ISSN:  1744-6880     ISO Abbreviation:  Pharmacogenet. Genomics     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-04-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101231005     Medline TA:  Pharmacogenet Genomics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  301-13     Citation Subset:  IM    
Affiliation:
Neuroscience Research Laboratories, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The bioartificial kidney: current status and future promise.
Next Document:  ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activi...